Information for investors and
media professionals
Financial calendar
ZKB Swiss Equities Conference, Zurich
2024 Full-year results
Annual General Meeting 2025
Ad hoc-News
Ad-hoc releases pursuant to art. 53 LR.
MEDIA RELEASES AND REPORTS
All necessary financial information of the company at a glance.
Key Figures full-year 2023
Share Information
Corporate Governance
Medartis relies on efficient cooperation between the Board of Directors and the company management. We respect the interests of our shareholders and rely on clear rules in addition to open, transparent corporate communication.
NAME | POSITION | COMMITTEE MEMBERSHIP | FIRST ELECTED | END CURRENT PERIOD | |
Marco Gadola | Chairman | Member HRCC | 2021 | 2025 | + |
Dr. h.c. Thomas Straumann | Vice Chairman | Member SIC | 1998 | 2025 | + |
Willi Miesch | Member of the Board | Chair SIC | 2010 | 2025 | + |
Damien Tappy | Member of the Board | Chair HRCC | 2018 | 2025 | + |
Nadia Tarolli Schmidt | Member of the Board | Chair FAC | 2022 | 2025 | + |
Ciro Roemer | Member of the Board | Chair UEC | 2022 | 2025 | + |
Martha Shadan | Member of the Board | Member UEC | 2024 | 2025 | + |
Jennifer Dean | Member of the Board | Member FAC | 2024 | 2025 | + |
HRCC = Human Resources and Compensation Committee | SIC = Strategy and Innovation Committee | FAC = Finance and Audit Committee | UEC = US Expansion Committee
Analyst Coverage
The following analysts evaluate the performance of Medartis stock and the investment opportunities for investors.
Stifel Nicolaus Europe Limited
Dylan Van Haaften
150 Cheapside
EC2V 6ET London
Zürcher Kantonalbank
Edouard Riva
Bahnhofstrasse 9
CH-8001 Zurich
Bryan Garnier & Co.
Maria Vara
Strawinskylaan 4117
1077 ZX Amsterdam, Netherlands
OCTAVIAN
Sandra Dietschy
Hottingerstrasse 12
CH-8032 Zurich
Research Partners AG
Alexander Burgansky
Hottingerstrasse 12,
CH-8032 Zürich
Annual General Meeting
Subscribe to ad hoc-News
Would you like to be informed about Medartis at first hand? Register and receive our news in electronic form.
INVESTOR RELATIONS
—
CONTACT
Investor Relations:
investor.relations@medartis.com
Phone: +41 61 633 37 36
Media Relations:
corporate.communication@medartis.com
Phone: +41 61 633 37 34
Postal Address:
Medartis AG
Hochbergerstrasse 60E
CH-4057 Basel
Switzerland